ANTICYTOPLASMIC ANTIBODY - ANVISA Registration 10259610186

Access comprehensive regulatory information for ANTICYTOPLASMIC ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10259610186 and manufactured by AESKU DIAGNOSTICS. The registration is held by MEDIVAX INDÚSTRIA E COMÉRCIO LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, INOVA DIAGNOSTICS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10259610186
Registration Details
ANVISA Registration Number: 10259610186
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

AESKULISA PR3 sensitive
Risk Class II

Registration Details

10259610186

25351590041201782

68814961000173

Company Information

AESKU DIAGNOSTICS
Germany
PT: ALEMANHA

Dates and Status

Jan 08, 2018

VIGENTE

09/18/2025 19:00:01